Tofacitinib Citrate (CAS: *-29-9)

Effective Anti Tumor Inhibitor API Tofacitinib Citrate(CAS: *-29-9)Chemical InformationQuick Details:Product Name TasocitinibMolecular Formula C16H20N6O.C6H8O7Molecular Weight 504.49Storage 3years in -20oCTargets Abl c-Src Dosage 30 nM; intraperitoneal injectionTarget JAK3  JAK2 JAK1 ROCK2  LCKIC50 1 nM 20 nM 112 nM 3.4 μM 3.87 μMProduct Name: Tofacitinib CitrateOther Names: 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1);1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);Tofacitinib citrate (CP-*);Tofacitinib citrate;Tasocitinib citrate;Tasocitinib citric acid s...;Xeljanz;CP-* (Tofacitinib citrate)Other Names:1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1);1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);Tofacitinib citrate (CP-*);Tofacitinib citrate;Tasocitinib citrate;Tasocitinib citric acid s...;Xeljanz;CP-* (Tofacitinib citrate)CAS No.: *-29-9MF: C16H20N6O.C6H8O7MW: 504.497Appearance:White or Nearly White Crystalline PowderPurity: 99%+Specifications:Pharmaceutical Grade MOQ):10gPacking: Aluminium Foil Bag or as Required   Product DescriptionTofacitinib (formerly tasocitinib, CP-*) is a drug being investigated for the treatment of rheumatoid arthritis (RA), psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. It is an inhibitor of the enzyme Janus kinase 3 (JAK3), which means that it interferes with the JAK-STAT signaling pathway that transmits information outside the cell into the cel
Tofacitinib Citrate (CAS: *-29-9)